Neonatal Medicine

The Korean Society of Neonatology (대한신생아학회)
권호 표지
DOI QR코드

DOI QR Code

KCNQ2 Encephalopathy Showing a Distinct Ictal Amplitude-Integrated Electroencephalographic Pattern

  • Kwak, Naeun (Department of Pediatrics, School of Medicine, Kyungpook National University) ;
  • Lee, Yun Jeong (Department of Pediatrics, School of Medicine, Kyungpook National University) ;
  • Kim, Dongsub (Department of Pediatrics, School of Medicine, Kyungpook National University) ;
  • Hwang, Su-Kyeong (Department of Pediatrics, School of Medicine, Kyungpook National University) ;
  • Kwon, Soonhak (Department of Pediatrics, School of Medicine, Kyungpook National University) ;
  • Lee, Eun Joo (Department of Pediatrics, School of Medicine, Kyungpook National University)
  • Received : 2020.08.05
  • Accepted : 2020.10.15
  • Published : 2020.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

KCNQ2 mutations induce a neonatal-onset epileptic encephalopathy of widely varying severity, ranging from benign familial neonatal epilepsy to severe refractory epileptic encephalopathy. Refractory seizures with KCNQ2 mutations have a positive response to sodium-channel blockers. Recently, a distinctive ictal pattern has been reported during amplitude-integrated electroencephalographic (aEEG) monitoring in infants with KCNQ2 encephalopathy. Herein, we describe a case of KCNQ2 encephalopathy with this distinctive ictal aEEG pattern, which was confirmed using conventional electroencephalography (EEG). A 3-day-old female infant presented with neonatal seizures accompanied by cyanosis and desaturation. Her seizure semiology was tonic and focal clonic. Her ictal aEEG demonstrated a sudden rise in amplitude followed by a suppressed background pattern. This pattern was also confirmed on conventional EEG. Her seizures were refractory despite the administration of multiple conventional antiepileptic drugs. Finally, c.794C>T; p. (Ala265Val) mutation was observed in the KCNQ2 gene on genetic testing, and she was diagnosed with KCNQ2 encephalopathy. Identifying this distinctive ictal pattern on aEEG monitoring facilitates the early detection of KCNQ2 encephalopathy and timely targeted treatment in patients with refractory seizures.

Keywords

References

  1. Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017;58:512-21. https://doi.org/10.1111/epi.13709
  2. Reif PS, Tsai MH, Helbig I, Rosenow F, Klein KM. Precision medicine in genetic epilepsies: break of dawn? Expert Rev Neurother 2017;17:381-92. https://doi.org/10.1080/14737175.2017.1253476
  3. Na JH, Shin S, Yang D, Kim B, Kim HD, Kim S, et al. Targeted gene panel sequencing in early infantile onset developmental and epileptic encephalopathy. Brain Dev 2020;42:438-48. https://doi.org/10.1016/j.braindev.2020.02.004
  4. Milh M, Boutry-Kryza N, Sutera-Sardo J, Mignot C, Auvin S, Lacoste C, et al. Similar early characteristics but variable neurological outcome of patients with a de novo mutation of KCNQ2. Orphanet J Rare Dis 2013;8:80. https://doi.org/10.1186/1750-1172-8-80
  5. Biervert C, Schroeder BC, Kubisch C, Berkovic SF, Propping P, Jentsch TJ, et al. A potassium channel mutation in neonatal human epilepsy. Science 1998;279:403-6. https://doi.org/10.1126/science.279.5349.403
  6. Dedek K, Fusco L, Teloy N, Steinlein OK. Neonatal convulsions and epileptic encephalopathy in an Italian family with a missense mutation in the fifth transmembrane region of KCNQ2. Epilepsy Res 2003;54:21-7. https://doi.org/10.1016/S0920-1211(03)00037-8
  7. Numis AL, Angriman M, Sullivan JE, Lewis AJ, Striano P, Nabbout R, et al. KCNQ2 encephalopathy: delineation of the electroclinical phenotype and treatment response. Neurology 2014;82:368-70. https://doi.org/10.1212/WNL.0000000000000060
  8. Kuersten M, Tacke M, Gerstl L, Hoelz H, Stulpnagel CV, Borggraefe I. Antiepileptic therapy approaches in KCNQ2 related epilepsy: a systematic review. Eur J Med Genet 2020;63: 103628. https://doi.org/10.1016/j.ejmg.2019.02.001
  9. Vilan A, Mendes Ribeiro J, Striano P, Weckhuysen S, Weeke LC, Brilstra E, et al. A distinctive ictal amplitude-integrated electroencephalography pattern in newborns with neonatal epilepsy associated with KCNQ2 mutations. Neonatology 2017;112:387-93. https://doi.org/10.1159/000478651
  10. Sands TT, Balestri M, Bellini G, Mulkey SB, Danhaive O, Bakken EH, et al. Rapid and safe response to low-dose carbamazepine in neonatal epilepsy. Epilepsia 2016;57:2019-30. https://doi.org/10.1111/epi.13596
  11. Shbarou R, Mikati MA. The expanding clinical spectrum of genetic pediatric epileptic encephalopathies. Semin Pediatr Neurol 2016;23:134-42. https://doi.org/10.1016/j.spen.2016.06.002
  12. Ambrosio AF, Silva AP, Malva JO, Soares-da-Silva P, Carvalho AP, Carvalho CM. Carbamazepine inhibits L-type Ca2+ channels in cultured rat hippocampal neurons stimulated with glutamate receptor agonists. Neuropharmacology 1999;38:1349-59. https://doi.org/10.1016/S0028-3908(99)00058-1
  13. Nguyen HM, Miyazaki H, Hoshi N, Smith BJ, Nukina N, Goldin AL, et al. Modulation of voltage-gated K+ channels by the sodium channel β1 subunit. Proc Natl Acad Sci U S A 2012;109: 18577-82. https://doi.org/10.1073/pnas.1209142109
  14. de Vries LS, Hellstrom-Westas L. Role of cerebral function monitoring in the newborn. Arch Dis Child Fetal Neonatal Ed 2005;90:F201-7. https://doi.org/10.1136/adc.2004.062745